Latest On GlycoMimetics, Inc (GLYC):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-30 15:17 EST | News | GlycoMimetics: Insider Buying Continues, And Chart Looks Healthy | N/A |  |
| 2023-05-10 16:14 EST | News | GlycoMimetics: An Asymmetric Opportunity That Could Change Hematology | N/A | |
| 2023-05-04 00:06 EST | News | GlycoMimetics, Inc. (GLYC) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-03 10:57 EST | News | GlycoMimetics GAAP EPS of -$0.17 in-line | N/A | |
| 2023-04-04 15:04 EST | News | GlycoMimetics Has Few Risks, Great Outlook In Leukemia | N/A | |
| 2023-03-29 13:01 EST | News | GlycoMimetics GAAP EPS of -$0.19 misses by $0.02 | N/A | |
| 2023-03-29 13:00 EST | News | GlycoMimetics, Inc. (GLYC) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-13 13:57 EST | News | RAPT Therapeutics, Repare Therapeutics among biotechs to disclose exposure to Silicon Valley Bank | N/A | |
| 2023-03-09 01:56 EST | News | GlycoMimetics: Stock Price Drop Brings Great Speculative Trade Opportunity | N/A | |
| 2023-02-22 13:21 EST | News | GlycoMimetics slips as chief scientific officer departs | N/A | |
| 2023-02-18 18:22 EST | News | Stocks To Watch: Retail Gets Tested With Walmart, Home Depot And CAGNY Conference On Tap | N/A | |
| 2023-02-17 16:57 EST | News | GlycoMimetics: Unraveling The Tea Leaves | N/A | |
| 2023-02-15 11:21 EST | News | GlycoMimetics sheds 39% after 11.8M stock offering | N/A | |
| 2023-01-03 16:22 EST | News | GlycoMimetics: A Cancer-Cure Lottery Ticket Grabbing My Attention | N/A | |
| 2022-11-12 05:25 EST | News | GlycoMimetics Could Surge If Q1 Data Readout Is Positive | N/A | |
| 2022-11-10 00:37 EST | News | GlycoMimetics GAAP EPS of -$0.16 beats by $0.10 | N/A | |
| 2022-11-10 00:36 EST | News | GlycoMimetics, Inc. (GLYC) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-09-06 09:09 EST | News | GlycoMimetics has a new Chief Medical Officer | N/A | |
| 2022-08-03 21:08 EST | News | GlycoMimetics GAAP EPS of $0.25 beats by $0.53, revenue of $75K | N/A | |
| 2022-08-03 21:07 EST | News | GlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-04-30 17:59 EST | News | GlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-04-28 13:35 EST | News | GlycoMimetics GAAP EPS of -$0.28 beats by $0.03 | N/A | |
| 2022-04-27 22:51 EST | News | GlycoMimetics Q1 2022 Earnings Preview | N/A | |
| 2022-03-17 10:10 EST | News | GlycoMimetics Positive Data For AML Therapy Increasingly Likely | N/A | |
| 2022-03-17 10:09 EST | News | GlycoMimetics' Uproleselan: Secondary Reasons To Own The Stock | N/A | |
| 2022-03-04 23:25 EST | News | GlycoMimetics files for $250M mixed shelf offering | N/A | |
| 2022-03-03 12:03 EST | News | GlycoMimetics GAAP EPS of -$0.33 beats by $0.01, revenue of $0.18M | N/A | |
| 2022-03-03 12:02 EST | News | GlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-02 17:47 EST | News | GlycoMimetics Q4 2021 Earnings Preview | N/A | |
| 2021-11-12 21:45 EST | News | GlycoMimetics A Buy On Nearing Trial Enrollment Completion | N/A | |
| 2021-11-02 16:41 EST | News | GlycoMimetics reports Q3 results | N/A | |
| 2021-11-02 16:40 EST | News | GlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-01 20:02 EST | News | GlycoMimetics Q3 2021 Earnings Preview | N/A | |
| 2021-09-26 20:14 EST | News | GlycoMimetics (GLYC) Investor Presentation - Slideshow | N/A | |
| 2021-09-24 05:04 EST | News | GlycoMimetics shares jump 12% after highlighting promising data from uproleselan leukemia trial | N/A | |
| 2021-08-08 12:49 EST | News | GlycoMimetics, Inc. (GLYC) CEO Rachel King on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-06 03:42 EST | News | GlycoMimetics EPS beats by $0.03 | N/A | |
| 2021-08-05 05:21 EST | News | GlycoMimetics names Harout Semerjian as chief executive officer | N/A | |
| 2021-07-23 00:09 EST | News | Treatment gets underway in early-stage leukemia trial of GlycoMimetics' uproleselan | N/A | |
| 2021-07-21 10:27 EST | News | GlycoMimetics says first patient dosed in investigator-sponsored mid-stage uproleselan study | N/A | |
| 2021-07-21 09:54 EST | News | Dosing gets underway in GlycoMimetics' uproleselan combination leukemia study | N/A | |
| 2021-05-03 23:14 EST | News | GlycoMimetics, Inc. (GLYC) CEO Rachel King on Q1 2021 Results - Earnings Call Transcript | N/A | |
| 2021-03-04 11:44 EST | Analyst Rating | The Analyst Target Price has decreased from $10.5 to $10.25. | Neutral | |
| 2021-03-04 07:43 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-03 11:42 EST | Earnings Estimate | An EPS average of -$1.36 is estimated for the 2022 year. | Sell | |
| 2021-03-03 11:42 EST | Earnings Estimate | An EPS average of -$0.31 is estimated for the quarter ending on June 30, 2021. | Buy | |
| 2021-03-03 07:24 EST | News | GlycoMimetics, Inc.'s (GLYC) CEO Rachel King on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-02 13:01 EST | News | GlycoMimetics EPS in-line, misses on revenue | N/A | |
| 2021-02-23 14:50 EST | News | GlycoMimetics picks internal candidate for chief medical officer | N/A | |
| 2020-12-08 11:54 EST | Analyst Rating | The Analyst Target Price has increased from $9 to $10.5. | Buy | |
About GlycoMimetics, Inc (GLYC):
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. The company's drug candidate include rivipansel, a pan-selectin antagonist for the treatment of vaso-occlusive crisis in sickle cell disease. It is also developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as Phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing GMI-1359 to target E-selectin and a chemokine receptors. It also develops various other programs, including GMI-1687, an antagonist of E-selectin; and Galectin-3, a carbohydrate-binding protein. The company has a cooperative research and development agreement with the National Cancer Institute; and collaboration and license agreement with Apollomics for the development and commercialization of uproleselan and GMI-1687. GlycoMimetics, Inc. was founded in 2003 and is headquartered in Rockville, Maryland.
General
- Name GlycoMimetics, Inc
- Symbol GLYC
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 54
- Fiscal Year EndDecember
- IPO Date2014-01-10
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://glycomimetics.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 15.03
- Price/Book (Most Recent Quarter) 1.34
- Enterprise Value Revenue 3.72
- Enterprise Value EBITDA 0.09
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.28
- Next Year EPS Estimate -$1.40
- Next Quarter EPS Estimate -$0.33
- Operating Margin -507%
- Return on Assets -21%
- Return on Equity -36%
- Revenue 10.16 million
- Earnings Per Share -$1.28
- Revenue Per Share $0.22
- Gross Profit 10.16 million
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 177.14 million
- EBITDA -59150020
- Analyst Target Price $10.25
- Book Value Per Share $2.62
View More
Share Statistics
- Shares Outstanding 51.49 million
- Shares Float 31.78 million
- % Held by Insiders 215%
- % Held by Institutions 78.59%
- Shares Short 1.07 million
- Shares Short Prior Month 919111
- Short Ratio 1.15
- Short % of Float 4%
- Short % of Shares Outstanding 2%
View More
Technicals
- Beta 2.4
- 52 Week High $5.19
- 52 Week Low $1.94
- 50 Day Moving Average 3.61
- 200 Day Moving Average 3.56
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
GlycoMimetics, Inc (GLYC) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
GlycoMimetics, Inc (GLYC) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-02 | $163000 | -$0.32 | -$0.32 | 0.62% |
| 2020-09-30 | 2020-11-06 | $N/A | -$0.29 | -$0.32 | 8.43% |
| 2020-06-30 | 2020-07-31 | $N/A | -$0.32 | -$0.37 | 13.51% |
| 2020-03-31 | 2020-05-01 | $N/A | -$0.18 | -$0.29 | 37.93% |
| 2019-12-31 | 2020-02-28 | $N/A | -$0.34 | -$0.35 | 3.41% |
| 2019-09-30 | 2019-11-07 | $N/A | -$0.31 | -$0.41 | 23.46% |
| 2019-06-30 | 2019-08-01 | $N/A | -$0.37 | -$0.37 | 0% |
| 2019-03-31 | 2019-05-02 | $N/A | -$0.33 | -$0.36 | 7.3% |
| 2018-12-31 | 2019-03-06 | $N/A | -$0.32 | -$0.31 | -3.9% |
| 2018-09-30 | 2018-11-02 | $N/A | -$0.27 | -$0.32 | 16.49% |
| 2018-06-30 | 2018-08-09 | $N/A | -$0.26 | -$0.34 | 22.96% |
| 2018-03-31 | 2018-05-03 | $N/A | -$0.33 | -$0.28 | -17.86% |
| 2017-12-31 | 2018-03-06 | $N/A | -$0.27 | -$0.25 | -8.87% |
| 2017-09-30 | 2017-11-08 | $N/A | -$0.24 | -$0.30 | 18.64% |
| 2017-06-30 | 2017-08-03 | $N/A | -$0.30 | -$0.35 | 14.29% |
| 2017-03-31 | 2017-05-08 | $N/A | -$0.34 | -$0.36 | 5.56% |
| 2016-12-31 | 2017-03-01 | $-500 | -$0.36 | -$0.36 | 0% |
| 2016-09-30 | 2016-11-04 | $19000 | -$0.34 | -$0.42 | 18.07% |
| 2016-06-30 | 2016-08-04 | $N/A | -$0.41 | -$0.48 | 14.58% |
| 2016-03-31 | 2016-05-04 | $N/A | -$0.40 | -$0.46 | 13.04% |
| 2015-12-31 | 2016-02-29 | $36000 | -$0.47 | -$0.47 | 0% |
| 2015-09-30 | 2015-11-12 | $-20035000 | -$0.38 | -$0.40 | 5% |
| 2015-06-30 | 2015-08-06 | $20.04 million | $0.51 | -$0.40 | 227.5% |
| 2015-03-31 | 2015-05-05 | $N/A | -$0.37 | -$0.37 | 0% |
| 2014-12-31 | 2015-03-16 | $15.03 million | -$0.39 | -$0.22 | -77.27% |
| 2014-09-30 | 2014-10-31 | $-15027000 | -$0.35 | $0.21 | -266.67% |
| 2014-06-30 | 2014-07-31 | $15.03 million | $0.39 | $0.24 | 62.5% |
| 2014-03-31 | 2014-05-09 | $23.59 million | -$0.30 | -$0.30 | 0% |
GlycoMimetics, Inc (GLYC) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
GlycoMimetics, Inc (GLYC) Chart:
GlycoMimetics, Inc (GLYC) News:
Below you will find a list of latest news for GlycoMimetics, Inc (GLYC) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
GlycoMimetics, Inc (GLYC) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 1 | 1.15 | CALL | 0 | 32 | 368.78 | TRUE | 0 | 0 |
| 2024-05-17 | 2.5 | 0.3 | CALL | 475 | 2686 | 403.69 | FALSE | 0 | 0 |
| 2024-05-17 | 4 | 0.2 | CALL | 20 | 2075 | 452.96 | FALSE | 0.2 | 0 |
| 2024-05-17 | 5 | 0.11 | CALL | 29 | 292 | 420.65 | FALSE | -0.08 | -0.42 |
| 2024-05-17 | 6 | 0.45 | CALL | 0 | 58 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0.05 | CALL | 211 | 10968 | 423.74 | FALSE | -0.04 | -0.44 |
| 2024-05-17 | 1 | 0.2 | PUT | 364 | 8960 | 400.85 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 1.3 | PUT | 87 | 11582 | 445.16 | TRUE | 0.05 | 0.04 |
| 2024-05-17 | 4 | 2.4 | PUT | 0 | 485 | 438.08 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 3.3 | PUT | 0 | 12 | 783.22 | TRUE | 0 | 0 |
| 2024-05-17 | 6 | 0 | PUT | 0 | 0 | 555 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 5.55 | PUT | 0 | 20 | 646.51 | TRUE | 0 | 0 |
| 2024-06-21 | 1 | 1 | CALL | 0 | 51 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 2.5 | 0.7 | CALL | 48 | 2611 | 406.93 | FALSE | 0.05 | 0.08 |
| 2024-06-21 | 4 | 0.5 | CALL | 0 | 134 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0.43 | CALL | 33 | 3678 | 391.46 | FALSE | 0.05 | 0.13 |
| 2024-06-21 | 6 | 0.8 | CALL | 0 | 36 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 7.5 | 0.23 | CALL | 27 | 5654 | 353.29 | FALSE | -0.05 | -0.18 |
| 2024-06-21 | 1 | 0.35 | PUT | 124 | 2338 | 331.99 | FALSE | 0.05 | 0.17 |
| 2024-06-21 | 2.5 | 1.5 | PUT | 32 | 2669 | 345.22 | TRUE | -0.1 | -0.06 |
| 2024-06-21 | 4 | 2.9 | PUT | 179 | 6033 | 378.94 | TRUE | 2.9 | 0 |
| 2024-06-21 | 5 | 3.4 | PUT | 0 | 44 | 412.13 | TRUE | 0 | 0 |
| 2024-06-21 | 6 | 0 | PUT | 0 | 0 | 438.1 | TRUE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | PUT | 0 | 0 | 872.3 | TRUE | 0 | 0 |
| 2024-07-19 | 1 | 1.26 | CALL | 0 | 33 | 0 | TRUE | 0 | 0 |
| 2024-07-19 | 2 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 2.5 | 0.8 | CALL | 0 | 2394 | 271.98 | FALSE | 0 | 0 |
| 2024-07-19 | 3 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 4 | 0.5 | CALL | 0 | 2507 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 5 | 1.77 | CALL | 310 | 30 | 0 | FALSE | 1.77 | 0 |
| 2024-07-19 | 6 | 0.9 | CALL | 0 | 15 | 324.12 | FALSE | 0 | 0 |
| 2024-07-19 | 7.5 | 1.57 | CALL | 310 | 65 | 0 | FALSE | 1.57 | 0 |
| 2024-07-19 | 1 | 0.45 | PUT | 0 | 86 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 2 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-07-19 | 2.5 | 1.51 | PUT | 10 | 51 | 284.35 | TRUE | 1.51 | 0 |
| 2024-07-19 | 3 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-07-19 | 4 | 0 | PUT | 0 | 0 | 201.01 | TRUE | 0 | 0 |
| 2024-07-19 | 5 | 3.2 | PUT | 0 | 1 | 371.63 | TRUE | 0 | 0 |
| 2024-07-19 | 6 | 0 | PUT | 0 | 0 | 358.32 | TRUE | 0 | 0 |
| 2024-07-19 | 7.5 | 0 | PUT | 0 | 0 | 492.2 | TRUE | 0 | 0 |
| 2024-09-20 | 1 | 1.62 | CALL | 0 | 2 | 424.16 | TRUE | 0 | 0 |
| 2024-09-20 | 2.5 | 0.9 | CALL | 40 | 196 | 305.76 | FALSE | 0.9 | 0 |
| 2024-09-20 | 4 | 0.66 | CALL | 0 | 11782 | 240.69 | FALSE | 0 | 0 |
| 2024-09-20 | 5 | 0.5 | CALL | 20 | 4597 | 253.05 | FALSE | 0.5 | 0 |
| 2024-09-20 | 6 | 0.52 | CALL | 0 | 18 | 235.17 | FALSE | 0 | 0 |
| 2024-09-20 | 7.5 | 0.46 | CALL | 0 | 2713 | 238.69 | FALSE | 0 | 0 |
| 2024-09-20 | 1 | 0.47 | PUT | 0 | 195 | 258.43 | FALSE | 0 | 0 |
| 2024-09-20 | 2.5 | 1.65 | PUT | 0 | 3001 | 234.61 | TRUE | 0 | 0 |
| 2024-09-20 | 4 | 2.96 | PUT | 0 | 11 | 236.95 | TRUE | 0 | 0 |
| 2024-09-20 | 5 | 3.2 | PUT | 0 | 0 | 312.31 | TRUE | 0 | 0 |
| 2024-09-20 | 6 | 0 | PUT | 0 | 0 | 460.75 | TRUE | 0 | 0 |
| 2024-09-20 | 7.5 | 6.1 | PUT | 0 | 1 | 296.8 | TRUE | 0 | 0 |
| 2024-12-20 | 1 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-12-20 | 2 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 2.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 5 | 1.47 | CALL | 1 | 0 | 541.96 | FALSE | 1.47 | 0 |
| 2024-12-20 | 7.5 | 2.65 | CALL | 0 | 12 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 2 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-12-20 | 2.5 | 0 | PUT | 0 | 0 | 204.88 | TRUE | 0 | 0 |
| 2024-12-20 | 5 | 0 | PUT | 0 | 0 | 230.38 | TRUE | 0 | 0 |
| 2024-12-20 | 7.5 | 0 | PUT | 0 | 0 | 285.05 | TRUE | 0 | 0 |
Latest GLYC Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 5:30 PM EST | 100 | $0.6216 |
| Jun 13, 2022 6:41 PM EST | 85 | $0.6287 |
| Jun 13, 2022 7:01 PM EST | 100 | $0.6216 |
| Jun 13, 2022 7:58 PM EST | 100 | $0.6066 |
| Jun 13, 2022 7:58 PM EST | 100 | $0.6066 |
GlycoMimetics, Inc (GLYC) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919120032315/0001209191-20-032315-index.htm |
| 2019-05-23 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1253689/000000000019008876/0000000000-19-008876-index.htm |
| 2019-01-28 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000003877719000032/0000038777-19-000032-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000008025519002657/0000080255-19-002657-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000008025520001261/0000080255-20-001261-index.htm |
| 2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000021545719006611/0000215457-19-006611-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000031506619001057/0000315066-19-001057-index.htm |
| 2019-08-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000031506619001676/0000315066-19-001676-index.htm |
| 2019-09-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000031506619001702/0000315066-19-001702-index.htm |
| 2018-09-06 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000072888918001483/0000728889-18-001483-index.htm |
| 2019-01-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000072888919000038/0000728889-19-000038-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000083423720005369/0000834237-20-005369-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000090221919000165/0000902219-19-000165-index.htm |
| 2020-01-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000090221920000035/0000902219-20-000035-index.htm |
| 2020-04-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000090221920000372/0000902219-20-000372-index.htm |
| 2019-06-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000091420819000279/0000914208-19-000279-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000091420820000058/0000914208-20-000058-index.htm |
| 2020-04-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000091420820000283/0000914208-20-000283-index.htm |
| 2020-07-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000091420820000361/0000914208-20-000361-index.htm |
| 2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000092189518000663/0000921895-18-000663-index.htm |
| 2019-08-15 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000092189519002247/0000921895-19-002247-index.htm |
| 2019-08-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000092189519002332/0000921895-19-002332-index.htm |
| 2019-09-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000092189519002380/0000921895-19-002380-index.htm |
| 2019-09-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000092189519002381/0000921895-19-002381-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000092189520000539/0000921895-20-000539-index.htm |
| 2020-11-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000092189520002779/0000921895-20-002779-index.htm |
| 2020-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000092189520002828/0000921895-20-002828-index.htm |
| 2020-07-20 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000093583620000390/0000935836-20-000390-index.htm |
| 2018-03-19 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1253689/000104746918001847/0001047469-18-001847-index.htm |
| 2018-03-21 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1253689/000104746918001954/0001047469-18-001954-index.htm |
| 2019-05-17 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1253689/000104746919003186/0001047469-19-003186-index.htm |
| 2020-10-07 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1253689/000104746920005139/0001047469-20-005139-index.htm |
| 2018-03-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000110465918019322/0001104659-18-019322-index.htm |
| 2019-05-23 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1253689/000110465919031465/0001104659-19-031465-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000114420419008076/0001144204-19-008076-index.htm |
| 2018-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919118009860/0001209191-18-009860-index.htm |
| 2018-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919118029614/0001209191-18-029614-index.htm |
| 2018-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919118029615/0001209191-18-029615-index.htm |
| 2018-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919118029616/0001209191-18-029616-index.htm |
| 2018-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919118029619/0001209191-18-029619-index.htm |
| 2018-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919118031812/0001209191-18-031812-index.htm |
| 2018-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919118031817/0001209191-18-031817-index.htm |
| 2018-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919118031825/0001209191-18-031825-index.htm |
| 2018-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919118031836/0001209191-18-031836-index.htm |
| 2018-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919118031842/0001209191-18-031842-index.htm |
| 2018-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919118031858/0001209191-18-031858-index.htm |
| 2018-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919118033068/0001209191-18-033068-index.htm |
| 2018-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919118037288/0001209191-18-037288-index.htm |
| 2018-10-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919118055586/0001209191-18-055586-index.htm |
| 2018-11-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919118060156/0001209191-18-060156-index.htm |
| 2018-11-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919118060160/0001209191-18-060160-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919119004821/0001209191-19-004821-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919119004823/0001209191-19-004823-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919119004825/0001209191-19-004825-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919119004827/0001209191-19-004827-index.htm |
| 2019-03-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919119017473/0001209191-19-017473-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919119031714/0001209191-19-031714-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919119031716/0001209191-19-031716-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919119031718/0001209191-19-031718-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919119031720/0001209191-19-031720-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919119031725/0001209191-19-031725-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919119031734/0001209191-19-031734-index.htm |
| 2019-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919119044967/0001209191-19-044967-index.htm |
| 2019-08-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919119046095/0001209191-19-046095-index.htm |
| 2019-12-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919119061782/0001209191-19-061782-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919120002098/0001209191-20-002098-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919120004814/0001209191-20-004814-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919120004818/0001209191-20-004818-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919120004824/0001209191-20-004824-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919120004826/0001209191-20-004826-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919120004828/0001209191-20-004828-index.htm |
| 2020-03-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919120017836/0001209191-20-017836-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919120032299/0001209191-20-032299-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919120032302/0001209191-20-032302-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919120032304/0001209191-20-032304-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919120032308/0001209191-20-032308-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919120032311/0001209191-20-032311-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1253689/000120919120032315/0001209191-20-032315-index.htm |
| 2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000142573818000010/0001425738-18-000010-index.htm |
| 2018-03-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837018001530/0001558370-18-001530-index.htm |
| 2018-03-06 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1253689/000155837018001553/0001558370-18-001553-index.htm |
| 2018-03-06 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1253689/000155837018001557/0001558370-18-001557-index.htm |
| 2018-04-13 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1253689/000155837018002958/0001558370-18-002958-index.htm |
| 2018-05-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837018003834/0001558370-18-003834-index.htm |
| 2018-05-03 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1253689/000155837018003836/0001558370-18-003836-index.htm |
| 2018-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837018004900/0001558370-18-004900-index.htm |
| 2018-07-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837018005686/0001558370-18-005686-index.htm |
| 2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1253689/000155837018006888/0001558370-18-006888-index.htm |
| 2018-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837018006892/0001558370-18-006892-index.htm |
| 2018-11-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837018008313/0001558370-18-008313-index.htm |
| 2018-11-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1253689/000155837018008314/0001558370-18-008314-index.htm |
| 2018-11-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837018009486/0001558370-18-009486-index.htm |
| 2019-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837019001513/0001558370-19-001513-index.htm |
| 2019-03-06 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1253689/000155837019001537/0001558370-19-001537-index.htm |
| 2019-03-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837019001547/0001558370-19-001547-index.htm |
| 2019-03-06 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1253689/000155837019001578/0001558370-19-001578-index.htm |
| 2019-04-10 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1253689/000155837019002905/0001558370-19-002905-index.htm |
| 2019-05-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837019003802/0001558370-19-003802-index.htm |
| 2019-05-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1253689/000155837019003803/0001558370-19-003803-index.htm |
| 2019-05-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837019005190/0001558370-19-005190-index.htm |
| 2019-08-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1253689/000155837019006741/0001558370-19-006741-index.htm |
| 2019-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837019006743/0001558370-19-006743-index.htm |
| 2019-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837019007085/0001558370-19-007085-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1253689/000155837019010290/0001558370-19-010290-index.htm |
| 2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837019010292/0001558370-19-010292-index.htm |
| 2019-11-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837019011165/0001558370-19-011165-index.htm |
| 2020-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837020000060/0001558370-20-000060-index.htm |
| 2020-02-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837020000636/0001558370-20-000636-index.htm |
| 2020-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1253689/000155837020001723/0001558370-20-001723-index.htm |
| 2020-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837020001731/0001558370-20-001731-index.htm |
| 2020-02-28 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1253689/000155837020001772/0001558370-20-001772-index.htm |
| 2020-04-16 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1253689/000155837020003935/0001558370-20-003935-index.htm |
| 2020-05-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1253689/000155837020004879/0001558370-20-004879-index.htm |
| 2020-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837020004881/0001558370-20-004881-index.htm |
| 2020-05-08 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1253689/000155837020005890/0001558370-20-005890-index.htm |
| 2020-05-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837020006971/0001558370-20-006971-index.htm |
| 2020-07-31 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1253689/000155837020008841/0001558370-20-008841-index.htm |
| 2020-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837020008848/0001558370-20-008848-index.htm |
| 2020-10-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837020011405/0001558370-20-011405-index.htm |
| 2020-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1253689/000155837020013021/0001558370-20-013021-index.htm |
| 2020-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1253689/000155837020013033/0001558370-20-013033-index.htm |
| 2019-08-15 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1253689/000165495419009665/0001654954-19-009665-index.htm |
| 2019-05-28 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1253689/999999999519001225/9999999995-19-001225-index.htm |
GlycoMimetics, Inc (GLYC) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of GlycoMimetics, Inc (GLYC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 215%Institutional Ownership: 7859%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-06-11 | Brian M. Hahn | CFO | Sell | 19,345.00 | 18.04 | 348,983.80 | 0.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919118037288/0001209191-18-037288-index.htm |
| 2018-05-23 | John L. Magnani | SVP of Research, CSO | Buy | 1,491.00 | 0.33 | 492.03 | 100,793.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919118033068/0001209191-18-033068-index.htm |
| 2019-08-13 | DANIEL M JUNIUS | Director | Buy | 10,000.00 | 3.18 | 31,800.00 | 18,000.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919119046095/0001209191-19-046095-index.htm |
| 2019-12-20 | John L. Magnani | SVP of Research, CSO | Buy | 106,984.00 | 1.12 | 119,822.08 | 182,777.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919119061782/0001209191-19-061782-index.htm |
| 2018-06-11 | Brian M. Hahn | CFO | Buy | 5,260.00 | 1.12 | 5,891.20 | 19,345.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919118037288/0001209191-18-037288-index.htm |
| 2020-01-06 | John L. Magnani | SVP of Research, CSO | Buy | 106,983.00 | 1.12 | 119,820.96 | 289,760.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919120002098/0001209191-20-002098-index.htm |
| 2019-09-05 | PARTNERS L P/IL BVF | 10% Share Holder | Buy | 689,834.00 | 3.18 | 2,195,051.79 | 2,955,440.00 | https://www.sec.gov/Archives/edgar/data/1253689/000092189519002381/0000921895-19-002381-index.htm |
| 2019-08-06 | Rachel K. King | President, CEO | Buy | 166,759.00 | 1.12 | 186,770.08 | 307,144.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919119044967/0001209191-19-044967-index.htm |
| 2020-10-30 | PARTNERS L P/IL BVF | 10% Share Holder | Buy | 250,755.00 | 2.75 | 689,576.25 | 3,206,195.00 | https://www.sec.gov/Archives/edgar/data/1253689/000092189520002779/0000921895-20-002779-index.htm |
| 2019-09-05 | PARTNERS L P/IL BVF | 10% Share Holder | Buy | 853,956.00 | 3.18 | 2,717,287.99 | 3,639,935.00 | https://www.sec.gov/Archives/edgar/data/1253689/000092189519002381/0000921895-19-002381-index.htm |
| 2020-11-04 | PARTNERS L P/IL BVF | 10% Share Holder | Buy | 506,155.00 | 2.60 | 1,316,003.00 | 3,712,350.00 | https://www.sec.gov/Archives/edgar/data/1253689/000092189520002828/0000921895-20-002828-index.htm |
| 2020-03-09 | DANIEL M JUNIUS | Director | Buy | 20,000.00 | 3.40 | 68,000.00 | 38,000.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919120017836/0001209191-20-017836-index.htm |
| 2020-10-30 | PARTNERS L P/IL BVF | 10% Share Holder | Buy | 666,385.00 | 2.75 | 1,832,558.75 | 4,306,320.00 | https://www.sec.gov/Archives/edgar/data/1253689/000092189520002779/0000921895-20-002779-index.htm |
| 2018-05-10 | ENTERPRISE ASSOCIATES 10 L P NEW | 10% Share Holder | Sell | 4,006.00 | 17.81 | 71,346.86 | 4,702,791.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919118029614/0001209191-18-029614-index.htm |
| 2018-05-10 | M JAMES BARRETT | Director | Sell | 4,006.00 | 17.81 | 71,346.86 | 4,702,791.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919118029615/0001209191-18-029615-index.htm |
| 2018-05-10 | PETER J BARRIS | 10% Share Holder | Sell | 4,006.00 | 17.81 | 71,346.86 | 4,702,791.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919118029616/0001209191-18-029616-index.htm |
| 2018-05-10 | SCOTT D SANDELL | 10% Share Holder | Sell | 4,006.00 | 17.81 | 71,346.86 | 4,702,791.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919118029619/0001209191-18-029619-index.htm |
| 2020-11-04 | PARTNERS L P/IL BVF | 10% Share Holder | Buy | 674,492.00 | 2.60 | 1,753,679.20 | 4,980,812.00 | https://www.sec.gov/Archives/edgar/data/1253689/000092189520002828/0000921895-20-002828-index.htm |
| 2018-05-10 | ENTERPRISE ASSOCIATES 10 L P NEW | 10% Share Holder | Sell | 5,533.00 | 17.81 | 98,542.73 | 4,995,664.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919118029614/0001209191-18-029614-index.htm |
| 2018-05-10 | M JAMES BARRETT | Director | Sell | 5,533.00 | 17.81 | 98,542.73 | 4,995,664.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919118029615/0001209191-18-029615-index.htm |
| 2018-05-10 | PETER J BARRIS | 10% Share Holder | Sell | 5,533.00 | 17.81 | 98,542.73 | 4,995,664.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919118029616/0001209191-18-029616-index.htm |
| 2018-05-10 | SCOTT D SANDELL | 10% Share Holder | Sell | 5,533.00 | 17.81 | 98,542.73 | 4,995,664.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919118029619/0001209191-18-029619-index.htm |
| 2019-09-05 | PARTNERS L P/IL BVF | 10% Share Holder | Buy | 124,956.00 | 3.18 | 397,609.99 | 528,891.00 | https://www.sec.gov/Archives/edgar/data/1253689/000092189519002381/0000921895-19-002381-index.htm |
| 2020-10-30 | PARTNERS L P/IL BVF | 10% Share Holder | Buy | 15,472.00 | 2.75 | 42,548.00 | 544,363.00 | https://www.sec.gov/Archives/edgar/data/1253689/000092189520002779/0000921895-20-002779-index.htm |
| 2020-11-04 | PARTNERS L P/IL BVF | 10% Share Holder | Buy | 86,090.00 | 2.60 | 223,834.00 | 630,453.00 | https://www.sec.gov/Archives/edgar/data/1253689/000092189520002828/0000921895-20-002828-index.htm |
| 2018-10-18 | John L. Magnani | SVP of Research, CSO | Sell | 3,527.00 | 14.02 | 49,448.54 | 75,793.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919118055586/0001209191-18-055586-index.htm |
| 2018-10-17 | John L. Magnani | SVP of Research, CSO | Sell | 7,273.00 | 14.00 | 101,822.00 | 79,320.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919118055586/0001209191-18-055586-index.htm |
| 2018-10-16 | John L. Magnani | SVP of Research, CSO | Sell | 14,200.00 | 14.01 | 198,942.00 | 86,593.00 | https://www.sec.gov/Archives/edgar/data/1253689/000120919118055586/0001209191-18-055586-index.htm |